|
|
|
|
|
19.10.26 - 18:42
|
Trump Dangles $100 Million Kentucky Pharma Investment, But Only If Republicans Win Midterms (ZeroHedge)
|
|
|
Trump Dangles $100 Million Kentucky Pharma Investment, But Only If Republicans Win Midterms
Authored by Travis Gillmore via The Epoch Times,
President Donald Trump announced plans for the Department of War to invest $100 million to support a pharmaceutical company, with the offer conditional on Republicans winning the midterm elections next month.
President Donald Trump takes the stage at the Truist Arena on the campus of North Kentucky University in Highland Heights, Ky., on Oct. 17, 2026. Travis Gillmore/The Epoch TimesAntheia would receive the funds to boost production of ingredients used in medications at a facility in Winchester, Kentucky.
"That's a big revitalization project," Trump said during a rally in the Truist Arena at Northern Kentucky University. "But, if the Democrats win ... they wouldn't be able to do it. They wouldn't even know what you're talking about."
Details about the investment are limited. The Epoch Times reached out to the Department of War for clarification but d...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.10.26 - 16:12
|
Northwell CEO Says Health Care Model Must Change (Bloomberg)
|
|
|
Northwell Health President and CEO Dr. John D'Angelo tells Bloomberg This Weekend that the traditional US health care model is unsustainable and that improving affordability will require a greater focus on wellness, prevention and chronic disease. Speaking with hosts David Gura and Lisa Mateo, D'Angelo discusses workforce shortages, the financial pressures facing nonprofit hospitals and how AI could reduce administrative burdens while preserving the human role in consequential medical decisions. (Source: Bloomberg)...
|
|
|
|
|
17.10.26 - 08:09
|
Krankenkassen für Terminvergabe nach medizinischem Bedarf (DPA-AFX)
|
|
|
BERLIN (dpa-AFX) - Gesetzlich Versicherte sollen nach Ansicht des Spitzenverbands der gesetzlichen Krankenkassen bei der Vergabe von Arztterminen besser gestellt werden. "Wir müssen den Zugang zur ambulanten Versorgung so organisieren, dass Termine nach ......
|
|
|
|
|
|
|
17.10.26 - 04:12
|
M42 CEO on AI, genomics and the future of healthcare (CNBC)
|
|
|
M42 Group CEO Dimitris Moulavasilis discusses how the Abu Dhabi-based healthcare company is combining artificial intelligence, genomics and clinical services to reshape healthcare. He explores the group's international expansion, the Emirati Genome Programme and the potential for technology to help doctors identify health risks earlier and move healthcare towards prevention rather than treatment....
|
|
|
|
|
|